Recent Finacing
Recent Raise
Deargen develops Dr.UG, an end-to-end AI platform for target discovery, molecular design, synthesis, and preclinical drug development, and collaborates with pharma and medical centers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Deargen.
